To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Additive low-level laser therapy improves pain and ROM outcomes for subacromial syndrome

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
November 2013

Additive low-level laser therapy improves pain and ROM outcomes for subacromial syndrome

Vol: 2| Issue: 10| Number:37| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Additive effects of low-level laser therapy with exercise on subacromial syndrome: a randomised, double-blind, controlled trial

Clin Rheumatol. 2011 Oct;30(10):1341-6. doi: 10.1007/s10067-011-1757-7. Epub 2011 May 4

Contributing Authors:
SM Abrisham M Kermani-Alghoraishi R Ghahramani L Jabbari H Jomeh M Zare

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

80 patients suffering from subacromial syndrome were randomized to determine the efficacy of low-level laser therapy (LLLT) as an additive therapeutic measure to physical therapy. Patients were allocated to receive a 10-session, 2-week physical exercise program combined with either LLLT or sham-LLLT treatment. The results demonstrated that the addition of LLLT significantly improved pain and range...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue